Aura Biosciences

AURA · NASDAQ

$6.56+$0.27 (+4.29%)TodayMarket closed ·
Prev close $6.29

Who owns AURA

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 51.9% of AURA’s shares.

  • TCG Crossover Management, LLC9.2%
  • Montanova Capital, LLC7.0%
  • Frazier Life Sciences Management, L.P.6.9%
  • Long Focus Capital Management LLC4.9%
  • Next 6 largest institutions23.9%
  • All other shareholders48.1%
Top institutional holders of AURA
HolderShares% of shares
TCG Crossover Management, LLC9.53M9.22%
Montanova Capital, LLC7.21M6.97%
Frazier Life Sciences Management, L.P.7.10M6.86%
Long Focus Capital Management LLC5.12M4.95%
Adage Capital Management, L.P.4.64M4.49%
Caligan Partners, LP4.30M4.16%
BlackRock Institutional Trust Company, N.A.4.26M4.12%
Vanguard Capital Management, LLC4.10M3.96%
Forbion Capital Partners4.05M3.92%
OrbiMed Advisors, LLC3.33M3.22%

Largest mutual fund holders

Top mutual fund holders of AURA
HolderShares% of shares
Vanguard Total Stock Market Index Fund2.96M2.86%
Franklin Templeton Investment Funds -Biotechnology Discovery1.31M1.26%
iShares Russell 2000 ETF1.17M1.13%
Vanguard Extended Market Index Fund1.13M1.10%
Franklin Biotechnology Discovery Fund765.62K0.74%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $39.13M (2 trades) of AURA on the open market, with no buys.

Latest AURA insider transactions
InsiderTypeSharesValue
Kratz EricaAward199.12K—
Kratz EricaAward100.89K—
Abu-Absi SusanAward265.49K—
Abu-Absi SusanAward134.51K—
Elazzouzi AmyAward46.46K—
Elazzouzi AmyAward23.54K—
Hopkins Janet JillAward116.15K—
Hopkins Janet JillAward58.85K—
Person JulieAward212.39K—
Person JulieAward107.61K—

Short interest

Settled Sep 30, 2026

Shares short
10.37M
Days to cover
9.23
% of shares outstanding
10.02%
Average daily volume
1.12M
Change since last report
+47.0%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.